| [1] |
Louis DN, Perry A, Reifenberger G, et al. The 2016 world health organization classification of tumors of the central nervous system: a summary[J]. Acta Neuropathol, 2016, 131(6): 803-820.
|
| [2] |
Nebbioso A, Tambaro FP, Dell’Aversana C, et al. Cancer epigenetics: moving forward[J]. PLoS Genet, 2018, 14(6): e1007362.
|
| [3] |
Sidhu H, Capalash N. UHRF1: The key regulator of epigenetics and molecular target for cancer therapeutics[J]. Tumour Biol, 2017, 39(2): 1010428317692205.
|
| [4] |
Hashimoto H, Horton JR, Zhang X, et al. The SRA domain of UHRF1 flips 5-methylcytosine out of the DNA helix[J]. Nature, 2008, 455(7214): 826-829.
|
| [5] |
Zhong J, Shaik S, Wan L, et al. SCFβ-TRCP targets MTSS1 for ubiquitination-mediated destruction to regulate cancer cell proliferation and migration[J]. Oncotarget, 2013, 4(12): 2339-2353.
|
| [6] |
Zhou J, Wang J, Chen C, et al. USP7: target validation and drug discovery for cancer therapy[J]. Med Chem, 2017, 14(1): 3-18.
|
| [7] |
Allred DC, Clark GM, Elledge R, et al. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer[J]. J Natl Cancer Inst, 1993, 85(3): 200-206.
|
| [8] |
Oba-Shinjo SM, Bengtson MH, Winnischofer SM, et al. Identification of novel differentially expressed genes in human astrocytomas by cDNA representational difference analysis[J]. Brain Res Mol Brain Res, 2005, 140(1-2): 25-33.
|
| [9] |
Jia Y, Li P, Fang L, et al. Negative regulation of DNMT3A de novo DNA methylation by frequently overexpressed UHRF family proteins as a mechanism for widespread DNA hypomethylation in cancer[J]. Cell Discov, 2016, 2: 16007.
|
| [10] |
Soleimani A, Ghanadi K, Noormohammadi Z, et al. The correlation between miR-146a C/G polymorphism and UHRF1 gene expression level in gastric tumor[J]. J Dig Dis, 2016, 17(3): 169-174.
|
| [11] |
Liang J, Wang WF, Xie S, et al. Expression of β-transducin repeat-containing E3 ubiquitin protein ligase in human glioma and its correlation with prognosis[J]. Oncol Lett, 2015, 9(6): 2651-2656.
|
| [12] |
Ougolkov A, Zhang B, Yamashita K, et al. Associations among beta-TrCP, an E3 ubiquitin ligase receptor, beta-catenin, and NF-kappaB in colorectal cancer[J]. J Natl Cancer Inst, 2004, 96(15): 1161-1170.
|
| [13] |
Cheng C, Niu C, Yang Y, et al. Expression of HAUSP in gliomas correlates with disease progression and survival of patients[J]. Oncol Rep, 2013, 29(5): 1730-1736.
|
| [14] |
Cai JB, Shi GM, Dong ZR, et al. Ubiquitin-specific protease 7 accelerates p14(ARF) degradation by deubiquitinating thyroid hormone receptor-interacting protein 12 and promotes hepatocellular carcinoma progression[J]. Hepatology, 2015, 61(5): 1603-1614.
|
| [15] |
Song MS, Salmena L, Carracedo A, et al. The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network[J]. Nature, 2008, 455(7214): 813-817.
|
| [16] |
Wang Q, Ma S, Song N, et al. Stabilization of histone demethylase PHF8 by USP7 promotes breast carcinogenesis[J]. J Clin Invest, 2016, 126(6): 2205-2220.
|
| [17] |
Masuya D, Huang C, Liu D, et al. The HAUSP gene plays an important role in non-small cell lung carcinogenesis through p53-dependent pathways[J]. J Pathol, 2006, 208(208): 724-732.
|